Antioxidant therapy for chronic hepatitis C after failure of interferon: Results of phase II randomized, double-blind placebo controlled clinical trial Academic Article uri icon

Overview

MeSH Major

  • Antioxidants
  • Hepatitis C, Chronic
  • Interferons

abstract

  • Antioxidant therapy has a mild beneficial effect on the inflammatory response of chronic HCV infection patients who are non-responders to interferon. Combined antiviral and antioxidant therapy may be beneficial for these patients.

publication date

  • October 28, 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4171320

PubMed ID

  • 17879400

Additional Document Info

start page

  • 5317

end page

  • 23

volume

  • 13

number

  • 40